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Most human protein-coding genes can be transcribed into multiple possible distinct mRNA
isoforms. These alternative splicing patterns encourage molecular diversity and dysregula-
tion of isoform expression plays an important role in disease etiology. However, isoforms are
difficult to characterize from short-read RNA-seq data because they share identical subse-
quences and exist in tissue- and sample-specific frequencies. Here, we develop BIISQ, a
Bayesian nonparametric model to discover Isoforms and Individual Specific Quantification
from RNA-seq data. BIISQ does not require known isoform reference sequences but instead
estimates isoform composition directly with an isoform catalog shared across samples. We
develop a stochastic variational inference approach for efficient and robust posterior infer-
ence and demonstrate superior precision and recall for short read RNA-seq simulations and
simulated short read data from PacBio long read sequencing when compared to state-of-the-
art isoform reconstruction methods. BIISQ achieves the most significant gains for longer (in
terms of exons) isoforms and isoforms that are lowly expressed (over 500% more transcripts
correctly inferred at low coverage in simulations). Finally, we estimate isoforms in the
GEUVADIS RNA-seq data, identify genetic variants that regulate transcript ratios, and
demonstrate variant enrichment in functional elements related to mRNA splicing regulation.
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Introduction
Alternative splicing is the process by which a single protein-coding gene produces distinct mRNA
transcripts, which vary in usage of component exons 1. Isoforms can differ by alternative transcrip-
tion initiation sites, alternative usage of splice sites (either 5 donor or 3 acceptor sites), alternative
polyadenylation sites, or variable inclusion of entire exons or introns (Figure 1). Altogether,
alternative splicing enables the large diversity of mRNA expression levels or proteome composition
observed in eukaryotic cells, which is particularly important for regulating the context-specific
needs of the cell 2.
It is estimated that 95% of human protein-coding genes produce alternatively spliced mRNAs 1.
These splicing decisions are important drivers of many biological processes, with considerable
variation in splicing patterns across human tissues 3. For example, mutations in splicing regulatory
elements leading to disease pathogenesis and progression 1, 4–8 and mutations in protein domains
of specific splicing factors occur at a high rate in tumor cells, resulting in increased cellular
proliferation 9. Furthermore, proteins resulting from splicing variants often have distinct molecular
functions–for instance, the two variants of survivin have opposite functions: one with pro-apoptotic
and the other with anti-apoptotic properties 10.
Though there is increasing evidence of the biological importance of splicing processes, the
precise role of alternative isoforms in regulating complex phenotypes is still largely uncharacter-
ized. This gap in understanding is due, in part, to the difficulty of identifying and quantifying
isoforms with high accuracy from RNA-seq data 11. Transcript reconstruction is essential to
elucidate the role of gene expression in biological processes, because gene level quantification
is convoluted by the multiple transcribed isoforms for each gene. The difficulties in isoform
quantification stem from the tissue- and sample-specific composition and expression patterns of
isoforms, the lack of a complete reference for isoform composition, and low abundance levels
of many isoforms 2. Further, RNA-seq reads that overlap informative splice junctions are rare,
often noisy 12, and difficult to map to a reference genome 13. Improvements in reconstructing
and quantifying tissue- and sample-specific isoforms would enable substantial improvements in
understanding the role of alternative splicing in complex disease.
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Simple transcript
Alternative 5' splice site
Skipped exon
Alternative polyadenylation
Isoforms
Alternative transcript initiation
Alternative 3' splice site
Figure 1: A single gene may be transcribed into several distinct mRNA variants called
isoforms through alternative splicing mechanisms. This figure shows six common types of
splicing events (top to bottom): simple transcript; alternative transcription start site; alternative 5’
splice site; alternative 3’ splice site; skipped exon; and alternative polyadenylation.
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While many tools exist for isoform reconstruction using RNA-seq data, these methods have
a number of drawbacks. First, many quantification methods assume that a high-resolution isoform
sequence reference is available for each gene in the genome 14–16, which in practice is often not
available or incomplete for non-model organisms and rare tissue or disease samples 11. Second,
most methods consider a single sample in isolation, which fails to exploit the sharing of isoforms
across samples to gain power for identification of rare or low abundance isoforms 17–19. Third,
many methods make technology dependent assumptions by controlling for specific biases (e.g.,
non-uniform sampling of reads 20) that do not generalize to mixtures of existing technologies or
new technologies with different biases.
Our method, Bayesian isoform discovery and individual specific quantification (BIISQ), addresses
these limitations. First, BIISQ uses annotations of transcribed regions as prior information 21, 22, but
the number and composition of isoforms across samples are estimated directly from the data, and
the number of isoforms may grow with additional observations. Second, BIISQ explicitly captures
isoforms shared across samples using a Bayesian hierarchical admixture model, which models
multiple samples jointly and borrows statistical strength across samples to identify shared isoforms
that may be in low abundance across samples. Third, we assume that each nucleotide base in an
isoform has an independent frequency in the mapped reads allowing BIISQ to account for read
mapping biases in RNA-seq data 23.
We develop a computationally tractable stochastic variational inference (SVI) algorithm to
fit this model to RNA-seq data to estimate the structure of isoforms, probabilistically assign reads
to isoforms, and compute sample-specific and global isoform proportions 24. We compare and
validate BIISQ results on simulated data from the Benchmarker for Evaluating the Effectiveness
of RNA-Seq (BEERS) software 16 and from Pacific Biosciences (PacBio) Iso-seq data, which
produces approximately 1 − 10 Kb sequence reads potentially capturing full-length isoforms 25.
Finally, we apply BIISQ to a large RNA-seq data set from lymphoblastoid cell lines (LCLs) 26 to
identify the catalog of isoforms across samples. We use our catalog of sample-specific inferred
isoforms and genotype data to identify genetic variants associated with isoform ratios and assess
the functional significance of alternatively spliced genes and associated splicing variants.
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Results
The goal of isoform reconstruction and quantification is to robustly estimate both absolute and
relative mRNA isoform expression levels, for both lowly and highly expressed transcripts, for
each sample in a large RNA-seq data set from multiple sequenced samples. Our method, BIISQ,
approaches this problem by postulating a model of isoform composition and relative isoform
expression shared across samples. Specifically, BIISQ implements a Bayesian non-parametric
hierarchical model of RNA-seq reads and isoforms inspired by the hierarchical Dirichlet process 27,
and we use stochastic variational inference (SVI) methods for computationally tractable and robust
posterior inference 24.
The BIISQ model probabilistically maps each RNA-seq read into a distribution over isoform
exon compositions. Each sample is associated with its own distribution over isoforms, drawn from
a global distribution over an arbitrarily large catalog of isoforms. The exon composition of each
isoform is modeled with a structured prior over exon usage that constrains the space of possible
isoforms to those with support in the observed RNA-seq reads. The model allows for extending
the global isoform catalog by constructing novel isoforms given observed RNA-seq reads that
could not have been generated from the current isoform catalog. Importantly, in our model, exon
usage, RNA-seq read assignments, and the sample-specific and global isoform proportions are
interpretable model parameters that translate directly to isoform composition and population- and
sample-level isoform quantification (for details, see Methods).
Variational methods enable computationally tractable posterior inference in Bayesian nonpara-
metric models such as BIISQ when applied to large genomic data 28, 29. In brief, the posterior
distribution of the BIISQ model is intractable to compute directly; instead, we hypothesize a set
of tractable variational distributions over the latent variables. Then, we iteratively compute the
values of the variational distribution parameters that minimize the distance between the variational
and true posterior distribution with respect to the Kullback-Leibler divergence 30, 31. BIISQ imple-
ments stochastic variational inference (SVI), an extension of variational inference that uses random
subsets of the samples to compute each approximate update of the variational parameters 24. SVI
was previously applied in eXpress to efficiently assign ambiguously mapped sequence reads for
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transcript abundance estimation 32.
Related isoform quantification methods. Methods for jointly inferring and quantifying alter-
natively spliced transcripts can be broadly partitioned into categories based on the required level
of reference annotation 33. Transcriptome annotation dependent methods require complete anno-
tation of the genome and transcriptome, including a description of isoform transcripts sequences
and splice junctions 14–16. In contrast, annotation-free methods require neither transcriptome nor
genome annotations 17, 34, 35. A third category of methods requires annotations of transcribed
regions but is agnostic to isoform and splicing annotations 17–19; our method BIISQ is in this
category. Methods may exhibit characteristics shared across multiple of the three previously
mentioned categories. For example, Cufflinks has evaluation modes that can be annotation-free
or guided by reference annotations 17.
We compared results from BIISQ with three representative isoform reconstruction and quan-
tification methods: Cufflinks 17, CEM 19, and SLIDE 18. These methods were selected based
on the following criteria: i) the ability to use annotations of transcribed genomic regions for
isoform discovery and quantification, but no requirement for isoform transcripts or splice junction
annotations; ii) coverage of combinatorial and statistical approaches; iii) support for both single-
end and paired-end reads; and iv) high-quality performance in a recent benchmark study of isoform
detection and quantification 36.
Cufflinks uses a parsimonious approach to isoform discovery in order to find the minimal
number of transcripts to explain the aligned reads 17. After filtering erroneous spliced read align-
ments, aligned reads are to assigned vertices in an overlap graph, whose edges represent isoform
compatibility between aligned reads. Transcript assembly then reduces to finding a minimum
set of paths through the overlap graph such that each aligned read is part of a path. Transcript
quantification uses a generative model for RNA-seq reads to compute a maximum a posteriori
estimate of the isoform quantifications, extending an earlier unpaired model 37; confidence intervals
are estimated using importance sampling.
CEM, an extension to the method IsoLasso 38, constructs a connectivity graph to generate
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a set of candidate isoforms 19. CEM and IsoLasso model the coverage of aligned reads at each
location as a Poisson distribution and uses lasso regression to produce a set of inferred isoforms
and abundance levels. The principle difference between CEM and IsoLasso is the optimization
procedure: CEM uses expectation maximization (EM) while IsoLasso solves a quadratic program.
In our comparison, we preferred CEM because of the superior performance demonstrated on
benchmark data 39.
The sparse linear modeling for isoform discovery and abundance estimation (SLIDE) method
implements a statistical approach based on the start and end positions of aligned reads 18. SLIDE
computes the number of aligned read start and end positions that group into transcribed regions
of exons and organizes them into bins. Isoform proportions are quantified using a linear model
of the observed bin proportions; a modified lasso penalty limits the number and composition of
isoforms. In our methods comparison, we ran SLIDE using two distinct settings of the regular-
ization parameter, λ = 0.01 and λ = 0.2, which encourages more and fewer discovered isoforms,
respectively. We refer to results from SLIDE with these two parameter settings as SLIDE more
and SLIDE fewer below.
Evaluation criteria. We evaluated precision and recall for each method in terms of exact and
partial matches to simulated RNA-seq data 40. Precision and recall were calculated based on exact
full length isoform matches between simulated and estimated isoforms (Equation 4, Methods).
Partial precision and recall were calculated by defining imperfect matchings between each esti-
mated transcript and the true transcripts (see Methods and Supplementary Fig. 1). We controlled
for issues regarding exon identification by counting an exon as successfully inferred if any subse-
quence of the inferred isoform overlapped an exon in the gene annotation. Thus, reconstructing
any subsequence of an exon was equivalent to reconstructing the whole exon correctly.
RNA-sequencing simulation: BEERS. The first evaluated our model on simulated data gener-
ated using the benchmarker for evaluating the effectiveness of RNA-Seq software (BEERS) 16.
After removing genes with less than three exons, we divided RefSeq genes into three equally sized
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groups according to exon counts producing gene sets with 3− 6 exons, 7− 12 exons, and 13− 312
exons. We then simulated 10,000 single-end reads from 100 samples and 35 genes randomly
selected from each group (105 simulated genes in total) using simulator parameters to vary read
length and the number of distinct isoforms.
To test the accuracy of each method, we applied the four isoform quantification methods to
these simulated data and computed the precision and recall of the isoform discovery results—both
perfect and partial matches (Figure 2). For perfect matchings, BIISQ displayed significantly higher
precision and recall across the 105 genes (t-test, p ≤ 2.2 × 10−16). For partial matchings, BIISQ
showed significantly higher recall but lower precision than Cufflinks (t-test, p ≤ 2.2× 10−16). The
overall trend remains when considering the results factored by the number of exons in the gene or
the number of alternatively spliced transcripts. However, there are opportunities to improve BIISQ
performance in precision and recall for highly spliced genes (Supplementary Fig. 2) and genes
with a small number of exons (Supplementary Fig. 3). These results suggest that BIISQ makes
marginal sacrifices in false discovery rate (FDR) to identify a higher proportion of true isoforms
relative to Cufflinks.
0.439
0.682
0.307 0.516
BIISQ
CEM
CUFF
SLIDE_fewer
SLIDE_more
0.2 0.3 0.4 0.5 0.6 0.7
matched proportion of transcripts
precision
recall
Figure 2: Isoform discovery precision and recall for simulated data. Precision (red) and recall (blue) of
the results from BIISQ, CEM, Cufflinks (CUFF), and SLIDE (SLIDE more and SLIDE fewer) applied to the
BEERS simulated single-end RNA-seq data. The thick center bars denote the mean precision or recall and
the fill denotes twice the standard error. Transparent fill denotes partial precision and recall with a matching
threshold of 0.2. Across all methods, the best (partial) precision and recall values are annotated above their
respective data points.
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Next, to investigate the source of BIISQ’s increased precision and recall, we evaluated the
number of perfectly inferred isoform transcripts for the most lowly expressed transcript in each
gene. Across all samples in the simulated data, BIISQ, CEM, Cufflinks, SLIDE more, and SLIDE fewer
correctly inferred 3,011, 1,205, 996, 1,167, and 1,067, respectively, out of a total of 10,500 tran-
scripts (i.e., 105 genes and 100 samples per gene) highlighting that much of the recall gains of
BIISQ originated from isoform transcripts with low expression levels.
We assessed the quantification accuracy of each method by computing the correlation between
true and inferred normalized read counts (reads per kilobase of exon model per million mapped
reads, or RPKM). BIISQ inferred positive expression for 13,607 transcripts compared to 8,512,
8,428, 7,516, and 7,062 for SLIDE more, CEM, Cufflinks, and SLIDE fewer, respectively. We
found a wide range of expression level estimates from the four methods (Figure 3A), which
is typical of isoform quantification in human samples 40. Overall, BIISQ showed the highest
correlation of results across the BEERS data, followed by CEM and Cufflinks (BIISQ r = 0.539,
CEM r = 0.52, Cufflinks r = 0.514).
We next investigated the characteristics of inferred transcripts with positive predicted expres-
sion by each method. All methods inferred a similar number of transcripts when the number of
exons was small (at least three exons and at most six). However, BIISQ quantified over 2,300
additional transcripts compared to Cufflinks, CEM, and SLIDE for medium length transcripts
(total number of exons ∈ [7,12]) and at least 1,948 additional transcripts for larger transcripts
(total number of exons ∈ [13,312]; Supplementary Fig. 4). We also evaluated the number of
transcripts quantified in terms of coverage, or the number of bases sampled from the transcript with
simulated reads normalized by the transcript length. Consistent with our results on low frequency
transcripts, BIISQ correctly infers almost 500% more transcripts across samples for isoforms with
coverage < 5 within each sample (Supplementary Fig. 5). As coverage increases, the difference
in the number of transcripts correctly inferred between BIISQ and competing methods diminishes,
with SLIDE more inferring the largest number of transcripts across all samples for transcripts at
coverage ≥ 400 within each sample. These results highlight the benefits of BIISQ’s model based
approach to isoform sharing across samples.
9
Figure 3: Isoform quantification accuracy. Correlation between true RPKM and inferred RPKM
for (A) BEERS simulated data and (B) Iso-Seq simulated data. Pearson correlation coefficients for
results from BIISQ, CEM, Cufflinks, SLIDE more, and SLIDE fewer were (A) 0.539, 0.520, 0.514,
0.235, and 0.409, respectively, for BEERS simulated data and (B) 0.751, 0.223, 0.763, 0.313, and
0.446, respectively, for simulated data from Iso-Seq reads.
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Short read RNA-seq simulations from long-read RNA-seq data. The BEERS simulated RNA-
seq data models technology-specific biases of short read RNA-seq data but does not capture the
exon composition of true transcript isoforms. The Pacific Biosciences Iso-Seq protocol is a single
molecule transcriptome sequencing technology that offers read lengths of up to 10 Kb 25. Iso-
Seq reads may span entire RNA transcripts, making the characterization of isoform composition
straightforward relative to inference from short-read data, where each read may map to one of
many possible isoforms. Thus, long read sequencing provides a medium for experimentally driven
evaluation of isoform reconstruction; however, the cost and platform specific error rates make
this technology infeasible to replace short read RNA-seq in the near future, necessitating the
development of methods such as BIISQ for short read RNA-seq data. Further, while reconstruction
is aided by long reads, quantifying isoforms is challenging due to the high costs at the relatively low
throughput realized by Iso-Seq, making precision and recall the principle metrics for evaluation of
Iso-Seq data 41.
We simulated short-read RNA-seq data from full length Iso-Seq reads, which allows us to
precisely capture true isoform composition and proportions in simulated data. To do this, we
constructed a reference set of genes from the Iso-Seq human transcriptome reference samples of
heart and brain tissue. After mapping genes and transcripts across tissues, we identified seven
genes with two or more isoforms in the heart and brain tissues (see Supplementary Methods).
Iso-Seq reads have a different error profile than other short-read technologies, so we evaluated
both GMAP and STARlong’s Iso-Seq read alignments to the human genome version hg19 42
(Supplementary Figs. 6, 7). To sample paired-end short reads from the Iso-Seq reads, the simulator
copied the RNA sequence from the Iso-Seq read and the alignment from GMAP or STARlong. For
seven transcripts (Supplementary Table 1), we simulated reads with lengths 50 bp, 100 bp, and 200
bp for 50 replicates of brain and heart tissue Iso-Seq samples. We define transcript span relative to
the transcript sequence coverage of simulated reads; for example, a span of 0.5 indicates that short
reads were simulated until the simulated reads mapped to half the length of the Iso-Seq reads for a
specific transcript.
We first evaluated the accuracy of each method in terms of perfect and partial precision
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and recall. BIISQ achieved the highest precision and recall from both exact and partial matching
thresholds across the seven Iso-Seq transcripts (Figure 4A). This strong performance improvement
remains when partitioning the RNA-seq data by read length and span (Figure 4B, C). Importantly,
the performance of BIISQ, Cufflinks, and SLIDE fewer does not deteriorate substantially in either
precision or recall for paired-end short reads relative to the deterioration in performance from CEM
and SLIDE more (Figures 2 and 4A).
We then compared isoform quantifications across the four methods in the paired-end short
read data (Figure 3B). BIISQ computed positive quantifications for 5,595 transcripts while Cufflinks,
SLIDE fewer, SLIDE more, and CEM inferred 3,248, 2,170, 1,296, and 1,025 transcripts respec-
tively. Rankings of quantification results on paired-end data largely mirrored the BEERS simula-
tions and, in total, BIISQ and Cufflinks showed the highest average correlation across the BEERS
and Iso-Seq data (r¯ = 0.645, r¯ = 0.639). BIISQ and Cufflinks also showed the highest agreement
between any pair of distinct methods (r = 0.567, Supplementary Fig. 8). We also found that
BIISQ inferred more transcripts across all exon compositions (Supplementary Fig. 9) and all
spans (Supplementary Fig. 10) in the Iso-Seq data.
In theory, paired-end reads are more informative for isoform reconstruction and quantifica-
tion than single-end reads largely because reads sampled from the same fragment are transcript
specific and may span additional non-contiguous junctions. However, isoform transcripts often
share many splice junctions, making them difficult to deconvolve in short-read paired end data,
whereas dissimilar transcripts are easier to differentiate using unique splice junctions. The Iso-Seq
simulated data included transcripts with a lower average normalized distance between isoforms
(0.471) compared to the BEERS simulated data (0.584), making these gains in short-read paired-
end data difficult to achieve. This transcript similarity and complications in modeling the insert
length of paired-end data may have contributed to the dramatic decrease in CEM’s accuracy on the
Iso-Seq simulated data (Figure 4).
We investigated the run time of each method as functions of the number of exons, gene
length, read length, and span; BIISQ run times are averaged across 20 runs and do not include the
one-time preprocessing for converting aligned reads to read-terms (Supplementary Figs. 11-14).
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CEM was the most efficient method tested, followed closely by Cufflinks, while BIISQ and SLIDE
had the longest run times. However, isoform reconstruction can be parallelized at the level of
reference transcript, so difficulties associated with running multiple iterations of BIISQ on large
data may be reduced by having many compute nodes to process distinct genes in parallel. Gene
and read lengths had marginal effects on run time (Supplementary Figs. 11 and 12). However,
CEM and Cufflinks showed increased run time as a function of the number of exons (p-value for
linear regression of run time versus the number of exons for CEM and Cufflinks: p ≤ 8.79× 10−4
and p ≤ 1.64 × 10−3, respectively) and the span (linear regression of run time versus span p ≤
7.44× 10−5 and p ≤ 8.85× 10−5). SLIDE all exhibited increased run time as a function of exons
(p ≤ 6.16×10−6) but no significant increase for span (p ≤ 0.32). In contrast, the run time of BIISQ
shows no dependence on the number of exons (p ≤ 0.61) or span (p ≤ 0.29) (Supplementary Figs.
13 and 14); this efficiency is likely due to modeling reads as read-terms and the aggregation of
similar read-terms in the initial processing of the aligned sequence read input.
GEUVADIS RNA-seq data for 462 samples. Next, we applied BIISQ to RNA-seq data for
462 lymphoblastoid cell lines (LCLs) from the GEUVADIS RNA sequencing project for 1000
Genomes samples 26. We built a model of transcription for each gene from the human genome
annotations in GENCODE release 19 and mapped RNA-seq reads with STAR 2-pass to the human
genome version hg19 (Methods). Applying BIISQ to these data, we discovered 31,712 novel
and 14,044 known transcript isoforms with respect to the GENCODE database v19 transcript
isoform annotations, considering only perfect matches to isoform exon composition. When using a
matching threshold of 0.2, we discovered 24,871 novel and 20,885 known isoforms. The distribu-
tion of the number of isoforms per gene is peaked for genes with no evidence of alternative splicing
(one transcript) and heavily spliced genes (≥ 7 transcripts) although we note that this distribution
could be confounded by erroneous splice junctions and fragmented transcripts in the BIISQ output
(Online Methods and Supplementary Fig. 15) 12.
To investigate population and sex specific splicing patterns, we first analyzed transcript ratio
quantification patterns across all genes in the GEUVADIS data. We considered global signatures
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Figure 4: Comparison of methods on Iso-seq simulations. Precision (red) and recall (blue) of
the results from BIISQ, CEM, Cufflinks (CUFF), SLIDE more, and SLIDE fewer applied to (A)
the short-read data simulated from Iso-Seq reads; (B) simulated data split by read length; and (C)
simulated data split by span. Transparent fill denotes partial precision and recall with a matching
threshold of 0.2 The thick center bars denote the mean precision or recall, and the fill denotes
twice the standard error. The best (partial) precision and recall values are annotated above their
respective points.
of differential transcript ratio usage and did not find a significant difference in the average isoform
transcript counts across sex (χ2 test, p ≤ 0.99) or population (χ2 test, p ≤ 1) when counts were
aggregated across protein coding genes (Supplementary Fig. 15). We then computed population
and sex specific transcript ratio distributions for each protein coding gene independently using like-
14
lihood ratio (LR) tests (see Online Methods). We found 924 and 148 genes that show population-
specific and sex-specific transcript ratio distributions, respectively (χ2 test, Bonferroni-corrected
p ≤ 0.05; Supplementary Table 14). Gene PTPRN2 showed the most significant differential effects
of population on isoform ratios (LR test, Bonferonni-corrected p ≤ 2.2 × 10−16; Figure 5A, top).
Gene LGALS9B showed the most significant differential effects of sex on isoform ratios (LR test,
Bonferonni-corrected p ≤ 2.2 × 10−16; Figure 5A, bottom, B). Most samples express at most
two of the five isoform transcripts of LGALS9B, but females show more highly variable isoform
expression levels than males, in particular for isoform 5 (Figure 5B).
Next, due to scarce prior information on population or sex specific transcript ratios, we
validated these results by testing for over-representation of population (CEU, TSI, FIN, GBR,
YRI), European (EUR) vs. African (AFR) (termed super population), and sex specific variants
in the exonic and intronic regions of the 924 and 148 genes. We compared this set to variants in
background genes defined as non-overlapping gene regions in human genome version hg19. To
control for the correlation structure of variation throughout the genome, we preformed linkage dise-
quilibrium (LD) pruning by removing variants in high r2 with neighboring variation (see Methods).
We varied the minor allele frequency (MAF), population-, and sex-specific thresholds to test the
hypergeometric test’s sensitivity to the threshold. We found a significant over-representation of
population-specific variants at MAF ≥ 0.15 and a population threshold requiring ≥ 85% of
alleles in a sample to exist in a specific population (hypergeometric test, Bonferroni-corrected
p ≤ 1.8 × 10−5; Supplementary Table 2). We computed over-abundance tests for European
or African specific variants (Supplementary Table 3) and find that they require a much lower
threshold than the population tests (MAF=0.05, super population threshold=0.75, hypergeometric
test, Bonferroni-corrected p ≤ 1.42× 10−5), which is expected given that most of the GEUVADIS
sample is concentrated in the European population. We found similar significance for sex specific
variants (Supplementary Table 4) although assortment of variant alleles by sex follows more
closely Bernoulli(0.5) and thus the sex threshold is closer to 0.5 (MAF=0.05, sex threshold=0.60,
hypergeometric test, Bonferroni-corrected p ≤ 3.01× 10−4).
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Figure 5: Results for GEUVADIS data. (A) The isoform quantification distribution where color
denotes a unique isoform and each vertical bar is a single sample for genes PTPRN2 (top) and
LGALS9B (bottom). (B) Simplex plots for gene LGALS9B factored by sex. Each point (red for
female, black for male) represents a sample’s isoform composition distribution for the two isoforms
denoted on the bottom axis and the remaining isoforms at the top intersection point. (C) Matrix-
eQTL p-value distribution for (left) cis-trQTLs and (right) cis-eQTLs. (D) The density of cis-
trQTLs, LD pruned cis-trQTLs, and cis-eQTLs distances to the nearest canonical splice junctions
in GENCODE. (E) LCN8 contained The most significant cis-trQTL (p ≤ 2.2 × 10−16). Linear
and logistic regressions are shown in black and red. (F) Variant set enrichment scores (red points
denoting significance). The x-axis includes cis-regulatory annotations (histone modifications and
chromatin accessibility).
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Quantitative trait loci analysis in GEUVADIS. Expression quantitative trait loci (eQTLs) are
genomic regions that contain one or more genetic variants that influence mRNA expression 43;
eQTL studies have been indispensable for identifying the functional significance of phenotype-
associated variants from genome-wide association studies 44. While eQTL analyses capture the
differences in gene expression, or an aggregate of all gene transcripts, relative to a genotype,
more subtle relationships between genetic variation and each spliced transcript are obfuscated. We
validated the RNA isoforms in GEUVADIS that BIISQ identified by performing both cis-eQTL and
QTL mapping of transcript ratios (trQTL) using high-resolution genotype data available for each
of the GEUVADIS samples 26, 45 (see Methods).
We found an enrichment of cis-trQTLs p-values compared to a uniform distribution of p-
values obtained by permutations of the genotypes (Figure 5C (left)). We identified a total of 792
cis-trQTLs (FDR ≤ 0.05 after LD pruning) in 766 unique genes. We found that the cis-trQTLs,
and cis-eQTLs to a lesser degree, showed spacial clustering near splice junctions (Figure 5D). We
found an enrichment of cis-eQTLs (889,662 in total) across 11,687 unique genes (FDR ≤ 0.05;
Figure 5C (right)). A total of 511 genes with a cis-trQTL also had a cis-eQTL (66.7%) and 264
cis-trQTLs were also cis-eQTLs (33.33%). These results suggest that cis-trQTL signals may be
masked when restricting analysis to gene-level quantifications.
We then compared our results with the 419,983 and 19,741 cis-eQTLs in the EUR and YRI
populations respectively, 116,079 and 4,149 cis-trQTLs, and 639 unique cis-trQTL target genes (or
eGenes) identified in the GEUVADIS study 26. Only 17 of the 766 genes (2.2%) that we identified
as cis-trQTL eGenes were also annotated as eGenes in the GEUVADIS study. This result is likely
caused by different processing protocols for the GEUVADIS data (e.g., the GEUVADIS study
computed CEU and YRI QTLs separately) and the reference transcript methods used to quantify
isoforms in the GEUVADIS data. BIISQ does not rely on known transcript isoforms and thus does
not suffer from potential biases inherent in reference based isoform quantification.
We found significant correlation among BIISQ cis-eQTLs and the GEUVADIS study cis-
eQTLs (EUR: Supplementary Fig. 17; ρ = 0.76 and rs = 0.63, t-test, p ≤ 2.2 × 10−16 and YRI:
Supplementary Fig. 18; ρ = 0.56 and rs = 0.52, t-test, p ≤ 2.2× 10−16). There were not enough
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overlapping transcripts to compare BIISQ cis-trQTLs and the GEUVADIS study cis-trQTLs, but,
comparing the most significant cis-trQTLs for each gene between the BIISQ and GEUVADIS study
(EUR population) results did not show significant correlation (Supplementary Fig. 19; t-test, pρ =
0.49 and prs = 0.12). Interestingly, BIISQ cis-eQTLs were more highly correlated with BIISQ
cis-trQTLs (Supplementary Fig. 20; ρ = 0.74 and rs = 0.51) than GEUVADIS study cis-trQTLs
and cis-eQTLs (EUR: Supplementary Fig. 21; ρ = 0.3 and rs = 0.23 and YRI: Supplementary
Fig. 22; ρ = 0.18 and rs = 0.03).
Next, we quantified potentially novel biological insight uniquely enabled by BIISQ. We
computed genes with cis-trQTLs exclusively inferred by BIISQ compared to previous work 26.
The most significant cis-trQTL (rs7042091) was identified for gene LCN8 by BIISQ (FDR ≤ 0.05;
Figure 5E) both of which were not found in the GEUVADIS study (FDR < 0.05) 26. However, we
found evidence for a cis-eQTL at this SNP-gene pair in the GTEx study across a number of tissues
(most significant p-value in whole blood p ≤ 2.2 × 10−16) 3. Further, mutations in the SNCA
gene, typically expressed in neurons but also in LCLs, have been associated with Parkinson’s
disease and was among the 721 uniquely inferred genes with a significant cis-trQTL 46. It has
been demonstrated that alternatively spliced transcripts can cause protein misfolding 47 and the
misfolding of SNCA’s protein product has been suggested as a therapeutic target for Parkinson’s
disease treatment 48. The synthesis of these results suggest the alternatively spliced transcripts of
SNCA might be interesting targets for future research and demonstrate the unique utility of BIISQ.
To further characterize the functional relationships among these cis-trQTLs, we performed
variant set enrichment (VSE) analysis for regions associated with variable intron splicing events
identified by LeafCutter 8 and cis-regulatory elements (CREs) from ENCODE in a diverse set
of cell types, including LCLs 49–51. VSE is a statistical test that computes significant enrich-
ment or depletion of an associated variant set (cis-trQTLs) co-localized among a set of genomic
annotations. In particular, we computed enrichment of cis-trQTLs in sites associated with open
chromatin; these data include: (a) enhancer and promoter-like regions identified through DNase I
hypersensitive sites (DHS, including DNase I, H3K4me3, and H3K27ac) for B-cell samples; and
a synthesis of DNase I hypersensitivity, formaldehyde-assisted isolation of regulatory elements
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(FAIRE), and chromatin immunoprecipitation (ChIP) experiments provided by the ENCODE project
for (b) LCLs and (c) control cell types 52 (see Supplementary Table 6 for details). We found that cis-
trQTLs were significantly enriched in B-cells when considering only DHSs (Figure 5F: Bcell-2,4;
VSE, Bonferroni-corrected p ≤ 2.07×10−4 and p ≤ 6.39×10−6) but not when jointly considering
DHSs and H3K4me3 or DHSs and H3K27ac (Figure 5F: Bcell-1,3). Furthermore, cis-trQTLs were
significantly enriched for the combined DHSs, FAIRE, and ChIP LCL data (Figure 5F: LCL-1-5;
VSE, Bonferroni-corrected p ≤ 3.60 × 10−3, 2.94 × 10−5, 2.19 × 10−4, 4.35 × 10−3, 2.16 ×
10−5 respectively) and clusters of alternatively excised introns identified by LeafCutter (Figure 5F
LCClusters-1, VSE, Bonferroni-corrected p ≤ 1.57×10−5). We did not find significant enrichment
in the control cell-types besides embryonic stem cell (VSE, Bonferroni-corrected p ≤ 2.36×10−4),
cervical carcinoma cells (VSE, Bonferroni-corrected p ≤ 3.38 × 10−3), and mesoderm leukemia
cells (VSE, Bonferroni-corrected p ≤ 2.87×10−3) indicating that there may be significant sharing
of cis-trQTL related chromatin markers between these samples and LCLs (Figure 5F: samples
H1hescPk-1, Helas3Ifna4hPk-1, and K562Pk-1).
Finally, we quantified enrichment of eGenes in the Database for Annotation, Visualization
and Integrated Discovery (DAVID) 53 across nine annotation lists including the KEGG, SwissProt,
UniProt, and InterPro databases (Supplementary Table 7). We compiled sets of high confidence
isoforms for each gene by filtering out transcript isoforms not present in ≥ 10% of the samples.
We computed functional enrichment for the remaining eGenes, and genes with > 1, > 4 and
> 6 transcript isoforms using all annotated human genes as the background set. We found cis-
trQTL gene target enrichment in a single KEGG pathway, olfactory transduction (BH adjusted
p ≤ 2.5 × 10−3) (Supplementary Table 8). This pathway shows substantial transcript diversity:
more than two thirds of olfactory receptors have been estimated to be alternatively spliced 54. The
most significant enrichment for the SwissProt and UniProt seq-feature annotations across the > 1,
> 4, and > 6 gene sets were alternative splicing and splice variant respectively (BH adjusted
p ≤ 2.2 × 10−16) (Supplementary Tables 9-11). We found the most significant enrichment from
InterPro to be protein kinases (BH adjusted p ≤ 2.2 × 10−16) which have been shown to exhibit
high proteomic and functional diversity as the result of alternative splicing 55. These database
19
enrichment results support BIISQ’s ability to reconstruct biologically relevant alternatively spliced
gene sets.
Discussion
We presented a statistical model, BIISQ, for quantifying RNA isoforms, which shares strength
across samples to estimate isoforms (especially those at low abundance) without reference isoform
compositions. We described a stochastic variational inference method for fitting BIISQ to data that
allows our approach to scale to genome-wide study data; further, BIISQ showed increased effi-
ciency as the coverage or size of the gene increased in paired-end Iso-Seq data. We demonstrated
that our method improves substantially over three state-of-the-art methods in both precision and
recall of isoforms on two different types of simulated data with significant improvement for low
abundance transcripts. We applied BIISQ to the GEUVADIS RNA-seq data and identified known
and novel isoforms that we extensively validated, in part, by identifying cis-trQTLs that cluster
near known splice junctions and are significantly enriched in cis regulatory elements associated
with chromatin accessibility, histone modifications, and alternatively excised intron clusters.
BIISQ has several advantages over existing representations of RNA isoforms: 1) sample-
specific isoforms are drawn from a collection of global isoforms, which leads to higher power to
discover low frequency isoforms by sharing strength across samples; 2) a Bayesian hierarchical
approach enables the principled incorporation of high-quality prior information such as observed
variation in the exon composition of isoforms; and 3) a nonparametric approach allows us to
flexibly combine computationally tractable posterior inference with model selection (here, the
number of isoforms). BIISQ is guaranteed to converge to a local maximum, but the results on
BEERS and Iso-Seq data demonstrate that the quality of isoform reconstruction is improved from
taking the best (in the maximum a posteriori) solution from multiple random restarts.
Our results on GEUVADIS data show that BIISQ captures biologically interesting trends.
This is likely due to the fact that the potentially incomplete transcripts BIISQ computes are still
useful; in fact, many methods quantify alternatively spliced exons 14, 56 or excised introns 8 that
correspond to incomplete transcripts. This suggests that both the full-length and partial transcripts
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identified by BIISQ can be biologically meaningful and considered for downstream analyses. The
flexible and robust model for isoform identification and quantification from short-read RNA-seq
data in BIISQ enables a more precise estimate of transcript isoform levels than is currently available,
and opens the door to a better characterization of the cellular regulation and role of transcript
isoforms in complex systems.
Online Methods
The BIISQ model. A gene is defined as an ordered list of contiguous transcribed exons or retained
introns; we will refer to both DNA sequence types as exons for simplicity. A gene’s exons are
ordered from the 5’ to 3’ end of the gene, and gene transcripts are represented by an ordered list
of integers denoting the exons included in that transcript. The model observations are j = 1 : m
RNA-seq samples, each with i = 1 : nj reads mapped to a reference genome or transcriptome
(gene annotation). The ith read term includes the start and end of the mapped read sequence and
the exons that are covered; paired reads are modeled as two connected read terms. A gene includes
ι = 1 : E exons, and the set of global and sample-specific isoforms are indexed by k = 1 : K
and ` = 1 : L respectively. We represent the composition of an isoform as a binary vector where 1
signifies an exon is included, and a 0 encoded a spliced exon.
The BIISQ model assumes read term counts {x1, . . . , xv, . . . , xV } that are generated from
a multinomial distribution with probability vector determined by isoform k, which follows a
Dirichlet distribution βk ∈ RV .
βk ∼ Dirichlet(bk,1η1, . . . ,bk,V ηV ). (1)
The function bk,v maps read terms to exons
bk,v =
g(xv,b
′
k,ι)−  if g(xv,b′k,ι) = 1
g(xv,b
′
k,ι) +  if g(xv,b
′
k,ι) = 0
for v ∈ {1, 2, · · · , V } and ι ∈ {1, 2, · · · , E} (2)
where b′k,ι ∼ Bernoulli(pik), for ι ∈ {1, 2, · · · , E}, pik ∼ Beta(r, s), and g(xv,b′k,ι) = 1 if read term
xv maps to the composition of isoform k (Supplementary Methods). The hyperparameter  adds
uncertainty to the read term components of βk. βk has a degenerate Dirichlet distribution, which is
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defined over the sub-simplex given by the mapping function bk,v; this exon-to-read term mapping
encourages sparsity over the read terms.
The distribution of global isoforms follows a Dirichlet process with concentration parameter
ω and a uniform base distribution H = UN over the set of all isoforms, G0|ω,H ∼ DP(ω, UN).
The set of natural numbers N defines the set of possible isoforms through their binary encodings;
e.g., the number 5 encodes the isoform with the first and third exons included in a three exon
gene (101). Sample-specific isoforms are distributed according to a Dirichlet process with base
distribution G0, and concentration parameter α: Gj|α,G0 ∼ DP(α,G0). The sharing of the base
distribution G0 ensures isoforms are shared among the samples and the clustering property of
the Dirichlet process encourages observations to join existing isoforms (rich-get-richer property).
Sample-specific and global isoforms are related through a multinomial mapping variable cj,l and
the latent isoform assignment for each read is drawn from a multinomial distribution zj,i. Finally,
reads are drawn from a multinomial distribution with probability vector determined by the global
isoform, wj,i ∼ Multinomial(βcj,l′ ), l′ = zj,i. See Supplementary Methods, Supplementary Fig.
24, and Supplementary Tables 12 and 13 for details of the BIISQ model.
Posterior inference in BIISQ. We developed a stochastic variational inference (SVI) method to
tractably and robustly estimate posterior probabilities in the BIISQ model, following prior work
on SVI for the hierarchical Dirichlet process (HDP) 24. We modified this method for the BIISQ-
specific model parameters as follows: Variables pik and b’ were distributed as Beta-Bernoulli,
which models the probability that an exon is included in isoform k. The mapping function g(·)
relates the exon inclusion variables to the global isoform Dirichlet distribution over read-terms.
Sparsity in terms of the number of exons per isoform may be induced by controlling the hyper-
parameters of the Beta-Bernoulli hierarchy, which removes exons and reduces the probability of
emitting the corresponding read-terms in the Dirichlet distribution through the mapping function
g(·) (Supplementary Fig. 24). Thresholds defined in the following description of the inference
algorithm are configurable parameters.
To handle the expansion and contraction of the population-wide isoforms, we implemented a
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merge-propose-reduce step in SVI and executed this step every 30 iterations 57, 58. For every pair of
isoforms, the merge step calculates the likelihood of the data before and after merging the pair of
isoforms; if the likelihood is greater after the merge for each sample, the merge is accepted. BIISQ
proposes new isoforms by computing the union of exons in randomly sampled, poorly mapped
read-terms, where the likelihood of that read mapping to existing isoforms is < 0.5. If at least
one novel isoform is proposed, BIISQ reinitializes all variational parameters as defined by Supp.
Algorithm 1. Finally, the reduce step removes an isoform k from the local and global distributions
if, for all samples, there are no reads that map to isoform k with a probability > 0.01.
BEERS simulated data runs. Single-end simulated RNA-seq reads were generated by the bench-
marker for evaluating the effectiveness of RNA-Seq software (BEERS) 16. We divided RefSeq gene
models into three equally sized groups according to exon count, producing groups of genes with
3-6, 7-12, and 13-312 exons. For 35 randomly selected genes in each group, we sampled 10,000
error-free reads for seven parameter configurations: a fixed number of three novel transcripts with
varying read lengths in {50,200,400} and a fixed read length of 100 with a varying number of
novel transcripts in {2,3,4,6} (see Supplementary Methods). For each gene model, we sample
reads for 100 samples drawn from the aligned RNA-seq reads in the BEERS simulated read pool.
The start position of a read was sampled from a gamma distribution with a parameter that decreases
linearly with the position to simulate a 5’ bias. The exonic composition of a novel splice form was
generated by BEERS, and isoform proportions for each sample were sampled from a Dirichlet
distribution with concentration parameter 1.
Short read simulations from PacBio Iso-Seq long read data. We downloaded the full length
non-chimeric human transcriptome liver, heart, and brain data from the Iso-Seq protocol, which
included unaligned sequence reads and General Feature Format (GFF) reference files for each
tissue 25. The gene identifiers provided in the reference files were created independently for each
tissue, so we constructed a reference set of genes and their transcripts across tissues as follows. For
each gene, we created a standard set of exons by parsing its transcripts and collapsing overlapping
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exons in the GFF files. We then mapped genes across the three tissues based on a base-pair overlap
of 95% and discarded non-unique mappings. For each gene, we then mapped transcripts across
tissues based on a 95% overlap (see Supplementary Methods). This process was conservative by
design, leading to a confident baseline of cross-tissue isoforms. We found seven genes having
at least two transcripts isoforms shared across at least two tissues (see Supplementary Table 1):
BLOC1S6, ZFAND6, CYTH1, APP, C1orf43, SPARCL1, and RNF14. None of these genes were
found to be expressed in liver and thus the liver data was discarded.
We mapped the Iso-Seq reads to the gene sequences of the identified transcripts from human
genome version hg19 (Supplementary Table 1) using the GMAP and STARlong algorithms 42. We
built an Iso-Seq short-read simulator (ISSRS) that simulates short-reads from longer Iso-Seq reads.
The inputs to ISSRS are sequencing parameters, a gene reference file with exon boundaries, and
an aligned sequence read file. The outputs of ISSRS are aligned sequences in SAM format that
contain shorter sequence reads but retain the read mapping biases present in the Iso-Seq data by
copying the sequence position from the Iso-Seq reads. In brief, the simulator works as follows:
(1) compute Iso-Seq reads that map with high confidence to a known transcript; (2) for each read,
determine the amount of sampling based on input coverage; (3) sample reads by attempting to add
insert sizes distributed normally with mean 10 bp and 40 bp standard deviation; (4) output sampled
reads while preserving sequence and quality scores from the aligned Iso-Seq transcripts in SAM
and BIISQ format (see Supplementary Methods). For step (1), STARlong mappings yielded fewer
false positives than GMAP, but GMAP produced many more usable alignments (Supplementary
Figs. 6 and 7). For the seven transcripts identified across tissues (Supplementary Table 1), we
simulated reads with lengths 50 bp, 100 bp, and 200 bp and approximate coverage values of the
input Iso-Seq transcripts of 0.25, 0.5, and 1 for 50 samples from brain and heart tissues.
GEUVADIS RNA-seq data preparation. RNA-seq reads from EBV-transformed LCLs were
downloaded from the Genetic European Variation in Health and Disease (GEUVADIS) project 26.
BIISQ requires read-terms – mapped RNA-seq read start positions, end positions, and exons covered
tuples – and a model of transcription for each gene indicating contiguous transcribed subse-
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quences including exons or retained introns. To build the transcription model, we first extracted
the protein coding representative (as defined by ENCODE annotation “basic”) transcripts from the
comprehensive gene annotations in GENCODE release 19 for human genome assembly version
GRCh37.p13. We then built a set of representative exons for each protein coding gene. Most
genes had a single transcript annotated as basic; for the remaining genes, we kept the transcript
with the largest number of exons.
To build the read-terms, we mapped the raw RNA-seq reads with STAR 2-pass to the human
genome version 19. We removed unmapped reads or non-primary reads that failed quality checks
or were marked as duplicates. We computed the mapped reads that overlapped transcripts from
our model, producing an intersection file. The full catalog of read-terms is built from a first pass
through the intersection files of each sample; we then construct read-term expression files for each
sample from a second pass with the read-term catalog. A final step reduces the number of read
terms by collapsing terms with a similar start position and exon content to an approximate target
number of read-terms of 2500.
Cis-QTL mapping. We used Matrix eQTL 59 to compute linear regressions and perform associa-
tion mapping for local eQTLs and transcript ratio QTLs (cis-trQTLs) where the ratio of expression
levels for each isoform to all isoforms in a gene—or the transcript ratio—replaces the RPKM
values for each gene 60. The logistic regression in Figure 5E was computed using a generalized
linear quasibinomial model. We define the cis region of a gene as the genetic variants falling within
100 Kb of a gene’s transcription start or end site. Sex, population, the first three genotype principal
components, and 15 PEER factors estimated from the isoform ratio matrix were included as
covariates using a standard processing pipeline for RNA-seq data to control for population structure
and latent confounders 61 (Supplementary Fig. 16 and Supplementary Table 5). The expression
of cis-eQTLs were also quantile normalized and we removed genes with a single transcript or
fewer than three exons in the computation of cis-trQTLs. We generated the null distribution of p-
values by permuting genotype labels while keeping isoform ratio labels constant (Supplementary
Methods). To achieve well calibrated null hypothesis p-values and filter transcripts containing false
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splice junctions, transcripts with ratios of 0 or 1 in all samples, as well as, transcripts expressed in
less than 10% of the samples were discarded.
GEUVADIS functional assessment. The Database for Annotation, Visualization and Integrated
Discovery (DAVID v6.8, May 2016) analysis included functional enrichment for nine databases
(Supplementary Table 7) and used the default whole genome set of genes 53. To reduce the affects
of linkage disequilibrium (LD) on the variant set enrichment analysis, we computed LD blocks
for YRI, CEU, FIN, GBR, and TSI populations with a minimum MAF of 0.001, r2 of 0.8, and
genotyping rate of 0.8 using the rAggr interface to Haploview on the 1000 Genomes Project phase
3 data 62. Variant set enrichment analysis was run on the LD blocks for ENCODE Encyclopedia
3 annotations: DNaseI hypersensitive sites, H3K4me3, H3K27ac, annotations generated from a
chromatin state segmentation computational tool sourcing from the Broad Histone UCSC track
for nine factors and nine cell types, DNaseI/FAIRE/ChIP synthesis annotations from ENCODE
and OpenChrom 52, and LeafCutter clusters (Supplementary Table 6). Sample Gm12878HMM
was removed from enrichment analysis due to a non-normal null distribution (KS test, p ≤ 0.01),
which is required by VSE (Supplementary Fig. 23). We included annotations from LCLs as well
as several other cell types as controls: glioblastoma, cervical carcinoma, hepatocellular carcinoma,
trophoblast, and embryonic stem cells.
Population and sex specific splicing. Population and sex-specific transcript ratios were evalu-
ated based on a likelihood ratio test. The alternative hypothesis modeled sample transcript ratios as
draws from population and sex-specific Dirichlet distributions while the null hypothesis assumed
a global Dirichlet distribution. We computed the maximum likelihood estimates for parameters of
the global, population-specific, and sex-specific Dirichlet distributions. Genes were selected for
the isoform proportion plots (Figure 5A) based on the likelihood ratio test
2log
(
L(θˆCEU |xCEUtr ),L(θˆFIN |xFINtr ),L(θˆGBR|xGBRtr ),L(θˆTSI |xTSItr ),L(θˆY RI |xY RItr )
L(θˆALL|xALLtr )
)
∼ χ2
where θˆa are the maximum likelihood estimates for the parameters of the Dirichlet distribution for
population a, xtr are the sample transcript ratios and populations are denoted as superscripts. Sex
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specific likelihood ratio tests were calculated analogously.
The EUR vs. AFR, population, and sex specific variant enrichment analyses were computed
from the 1000 Genomes Project phase 3 main release data (human genome version hg19). We
describe the processing for population specific variants (sex specific and super population variants
follow analogously). First, to control for linkage disequilibrium (LD), we masked variants in
pairwise LD > 0.90 using PLINK v1.9 (indep-pairwise 100000 1000 0.9). We then extracted two
orthogonal sets of variants in protein coding gene regions: population specific genes (selected set)
and non-population specific genes (background set). For a specific variant, let the count of an allele
a in population p be denoted |a|p, the set of all alleles be A and the set of all populations P . Then,
a variant is population specific if
∃a,p | |a|
p∑
q∈P |a|q
> t (3)
for some population threshold t. Then, for each variant we count the number of population specific
alleles greater than a minor allele frequency threshold for our selected set and background set and
test for an abundance of selected population specific alleles with a hypergeometric test.
Parameter settings for each method. To run BIISQ, we initialized K = 1, allowing the global
distribution of isoforms for a given gene to consist of a single isoform expressing all exons. For the
BEERS simulations, we set BIISQ hyperparameters to maximize precision and recall on a random
held out RefSeq gene by grid-search. The hyperparameters were as follows: N − iter = 5000,
threads = 1, use− cython = 1, max− n− prop = 3, min− n− prop = 3, iter − prop = 30,
new−iso−prop = 2, red−iso−prop = 0, r = 0.7, s = 1, converge = 1e−3, α ∈ {15,100}, ω ∈
{8,50}, and η ∈ {8,50}. Solutions with the maximum likelihood were considered for evaluation.
Hyperparameters for PacBio runs were the same as BEERS except r = 1.1. For GEUVADIS,
hyperparameters were set to the same as PacBio with exceptions: alpha = 15, omega = 8,
eta = 8.
We ran related methods as follows:
• GMAP v.2015-12-31 63: -D [data dir] -d pacbio -f samse -n 0 -t 16
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--nofails [input fasta] > [output SAM] 2> [log file]
• starLONG v.020201 64: --genomeDir [genome reference] --runThreadN
1 --readFilesIn [input fasta] --outFileNamePrefix [output]
--runMode alignReads --outSAMattributes NH HI NM MD
--readNameSeparator space --outFilterMultimapScoreRange 1
--outFilterMismatchNmax 2000 --scoreGapNoncan -20
--scoreGapGCAG -4 --scoreGapATAC -8 --scoreDelOpen -1
--scoreDelBase -1 --scoreInsOpen -1 --scoreInsBase -1
--alignEndsType Local --seedSearchStartLmax 50
--seedPerReadNmax 100000 --seedPerWindowNmax 1000
--alignTranscriptsPerReadNmax 100000
--alignTranscriptsPerWindowNmax 10000
• CEM v.2.6 19: python runcem.py -x [BED reference] [input BAM]
• Cufflinks v.2.2.1 17: cufflinks --library-type ff-firststrand -g [GTF
reference] -o [output] [input BAM]
• SLIDE v.2012-02-17 (modification date) 18: python slide.py [GTF reference]
[BAM input] [GTF output] --read type mixed
Evaluation criteria. An isoform transcript is defined by the set of exons that are expressed from
a known gene reference. An evaluation criterion that requires the true and inferred exon sets
to be identical is often conservative due to variable read coverage of exons. Therefore, isoform
reconstruction was evaluated by considering both perfect and imperfect matchings to determine
precision and recall (Supplementary Fig. 1). For exact matches, precision and recall were calcu-
lated based on exact full length isoform matches between true (simulated) and estimated isoforms:
let true positives, false positives, and false negatives be denoted TP, FP, and FN respectively. Then,
precision =
TP
TP + FP
recall =
TP
TP + FN
(4)
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For inexact matches, partial precision and recall were calculated by defining a matching M , or a
set of pairs of inferred-true isoforms, that is of maximum cardinality and minimum weight (i.e.,
distance between isoform composition of a pair) between each computed transcript and the true
transcripts as follows. Let KC and KT be the set of estimated and true isoforms, respectively,
which are Boolean vectors of length E exons {1,2,...,E}. A 1 at position ι signifies that exon ι is
contained within that isoform, and k[ι] indexes the position of the Boolean vector k. We define the
distance between an inferred and true isoform dk,l for all k ∈ KC and l ∈ KT to be the Hamming
distance.
The Hamming distance counts the number of mismatched exons between the estimated
and true isoforms. The maximum cardinality minimum weight M is then the solution to the
optimization problem
minM =
∑
k∈1:KC
∑
`∈1:KT
xk`dk` (5)
s.t.
∑
k∈1:KC
xk` = 1 ∀` ∈ 1 : KT (6)
∑
`∈1:KT
xk` = 1 ∀k ∈ 1 : KC (7)
xk` ∈ {0,1} ∀k ∈ 1 : KC ,∀` ∈ 1 : KT (8)
If the total number of isoforms is I , finding a maximum cardinality minimum weight matching
can be solved in O(I3) time 65. If dk` is the distance between inferred isoform k ∈ KC and true
isoform ` ∈ KT for matching M , then dk,` = 0 (dk,` > 0) implies k is a true (false) positive;
if dk,` ≤ p|E| (dk,` > p|E|) then k is a p-partial true (false) positive (p-TP and p-FP). Any true
isoform not matched by a p-partial true positive is a p-partial false negative (p-FN). Using these
definitions of p-TP, p-FP, and p-FN, we can compute p-precision and p-recall as in Equation 4.
Software. The source code and software implementing the BIISQ model and inference methods
can be downloaded from: https://github.com/bee-hive/BIISQ.
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